Início › Colite ulcerativa › Nova York
Ensaios clínicos de Colite ulcerativa em Nova York
31 estudos para Colite ulcerativa estão buscando participantes em locais em Nova York.
Cidades em Nova York
Texto oficial do estudo (Inglês)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- New York Gastroenterology Associates - Upper East Side /ID# 281767, New York
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Westchester Putnam Gastroenterology PC, Carmel
- Five Towns Gastroenterology, Cedarhurst
- IMIDeology, Elmhurst
- e mais 5
RecrutandoFase 4
Idades de 18 a 80 · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06581328A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Ellipsis Research Group, Brooklyn
- Smart Medical Research - Jackson Heights, Jackson Heights
- Pioneer Clinical Research NY, New York
- e mais 1
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Albany
- Xencor Investigative Site, Rochester
RecrutandoFase 1/2Voluntários saudáveis bem-vindos
Idades de 18 a 75 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 037, New York
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-002, Albany
- Site US-016, Rochester
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07845487A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Intercity Gastroenterology, Fresh Meadows
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT06979336A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Westchester Putnam Gastroenterology, Carmel
- Inflammatory Bowel Disease Center at NYU Langone, New York
- Icahn School of Medicine at Mount Sinai, New York
- e mais 3
RecrutandoFase 3
Idades 12 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07196748A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Columbia University Medical Center, New York
RecrutandoFase 2/3
Idades de 2 a 17 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Icahn School of Medicine at Mount Sinai, New York
- New York Gastroenterology Associates, New York
- Care Access - Yonkers, Yonkers
RecrutandoFase 3
Idades de 18 a 70 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- e mais 1
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT03816345A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Icahn School of Medicine at Mount Sinai, New York
RecrutandoFase 3
Idades de 2 a 19 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT04844606LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Digestive Disease Medicine of Central New York, Utica
RecrutandoFase 2
Idades de 18 a 80 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07186101LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Stony Brook University, Stony Brook
RecrutandoFase 2
Idades de 18 a 80 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- NYU Langone Health, New York
- Weill Cornell Medical College- New York Presbyterian Hospital, New York
RecrutandoFase 4
Idades de 18 a 65 · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- MedTraits NY - Site Number: 8400045, Maspeth
- Weill Cornell Medicine - NewYork-Presbyterian Hospital - Site Number: 8400040, New York
- New York Gastroenterology Associates - Site Number: 8400009, New York
RecrutandoFase 3
Idades de 16 a 80 · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07185009Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- New York Gastroenterology Associates ( Site 0253), New York
RecrutandoFase 3
Todas as idades · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT06651281A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- New York Gastroenterology Associates, New York
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 28 de ago. de 2026 · NCT07577856A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
- Fink Children's Ambulatory Care Center, New York
- Kimmel Pavilion - NYU Langone, New York
- NYU Grossman School of Medicine, New York
- e mais 4
RecrutandoFase 2
Idades de 2 a 11 · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT07470879A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Columbia University Medical Center, New York
RecrutandoFase 2
Idades de 18 a 80 · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT06636656An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- MedTraits NY - Site Number: 8400045, Maspeth
- Manhattan Clinical Research, LLC - Site Number: 8400069, New York
- NYU Langone Health - Site Number: 8400091, New York
- e mais 4
RecrutandoFase 3
Idades de 16 a 80 · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT07184996Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Saratoga Schenectady Gastroenterology Associates, Burnt Hills
- NYU Langone Health, New York
- Cornell University, New York
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 7 de ago. de 2026 · NCT05230173BOOM-IBD2 Pivotal Clinical Trial
- Northwell Health North Shore University Hospital, Manhasset
- Columbia University Irving Medical Center/New York Presbyterian Hospital, New York
Recrutando
Idades de 18 a 85 · Todos os sexos · Atualizado em 6 de ago. de 2026 · NCT06571669Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- New York University, New York
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT07237516An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- NYU Langone Health, New York
- Lenox Hill Hospital, Northwell Health, New York
RecrutandoEstudo observacional
Idades de 18 a 64 · Todos os sexos · Atualizado em 9 de jul. de 2026 · NCT06398626A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- New York Presbyterian Hospital, New York
RecrutandoFase 3
Idades de 2 a 17 · Todos os sexos · Atualizado em 22 de jun. de 2026 · NCT06405087A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
- Investigational Site Number: 8400021, New York
- Investigational Site Number: 8400029, Queens Village
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 23 de abr. de 2026 · NCT06975722A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, New York
- Mirador Therapeutics Selected Site, Rochester
RecrutandoFase 2
Idades de 18 a 80 · Todos os sexos · Atualizado em 12 de mar. de 2026 · NCT07113522Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- State University of New York Upstate Medical University, Syracuse
Recrutando
Idades de 18 a 85 · Todos os sexos · Atualizado em 8 de jan. de 2026 · NCT05987852Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
- Bausch Health Site 006, The Bronx
RecrutandoFase 4
Idades de 5 a 17 · Todos os sexos · Atualizado em 16 de set. de 2025 · NCT04314375Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
- New York University, New York
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 8 de mai. de 2025 · NCT06750731Fonte: ClinicalTrials.gov, dados obtidos em 2 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.